Hervé Geneste

LY-2140023, a prodrug of the group II metabotropic glutamate receptor agonist LY-404039 for the potential treatment of schizophrenia.

Mario Mezler, Hervé Geneste, Laura M. Gault et al. · PubMed · 2010 · 48 citations

Psychopharmacology, Neuropsychiatry, Pharmacotherapy +16

Potent and selective oxindole-based vasopressin 1b receptor antagonists with improved pharmacokinetic properties

Thorsten Oost, Gisela Backfisch, Swati Bhowmik et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 46 citations · Full text

Improved Pharmacokinetic Properties, Functional Selectivity, Medicine +6

Site selective hydrogen/metal exchange: Competition and cooperation between superbases and neighboring groups

Manfred Schlosser, Ferenc Faigl, Livia Franzini et al. · Pure and Applied Chemistry · 1994 · 45 citations · Full text

Chemical Engineering, Engineering, Hydrogen Transition +6

Design and synthesis of 1,5- and 2,5-substituted tetrahydrobenzazepinones as novel potent and selective integrin αVβ3 antagonists

Andreas Kling, Gisela Backfisch, Jürgen Delzer et al. · Bioorganic & Medicinal Chemistry · 2003 · 43 citations

The Superbase Approach to Flurbiprofen: An Exercise in Optionally Site-Selective Metalation

Manfred Schlosser, Hervé Geneste · Chemistry - A European Journal · 1998 · 32 citations